Jenny V. Gunnarsson
AstraZeneca R&D
Moelndal, O, Sweden
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Adalimumab and infliximab are equally efficient in achieving sustained remission in ulcerative colitis but infliximab is superior in severe disease-a retrospective observational study.
Journal: Scandinavian journal of gastroenterology
Published: February 22, 2026
Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1.
Journal: ACS chemical biology
Published: June 20, 2025
Psychosocial aspects of sports injuries are on the agenda: but what can be measured and assessed during rehabilitation and return to sport?
Journal: British journal of sports medicine
Published: May 27, 2025
Protein Expression via Transient Transfection of Mammalian Cells in a WAVE Bioreactor.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 26, 2024
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Journal: Therapeutic advances in gastroenterology
Published: March 12, 2021
Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
Journal: The Journal of biological chemistry
Published: May 19, 2020
A class of highly selective inhibitors bind to an active state of PI3Kγ.
Journal: Nature chemical biology
Published: July 06, 2018
Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain.
Journal: Scandinavian journal of gastroenterology
Published: January 17, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026